Enhancement of the effect of 5-aminolevulinic acid-based photodynamic therapy by simultaneous hyperthermia

International Journal of Oncology

Volumn 27, Issue 1, 2005, Pages 193-201

  Yanase, Sigeaki ^a   Nomura, Jouji ^a   Matsumura, Yoshihiko ^a   Nagai, Koyu ^a   Kinoshita, Machiko ^a   Nakanishi, Hiroki ^a   Ohnishi, Yasuhiro ^a   Tokuda, Tohru ^a   Tagawa, Toshiro ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ALA; Hyperthermia; Osteosarcoma; PDT; Squamous cell carcinoma

Indexed keywords

AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENT; CHAPERONIN; HEAT SHOCK PROTEIN 70; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN;

ARTICLE; CELL MEMBRANE POTENTIAL; CELL SEPARATION; DOSE RESPONSE; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HYPERTHERMIC THERAPY; LIGHT; METABOLISM; METHODOLOGY; MITOCHONDRION; OSTEOSARCOMA; PATHOLOGY; PHASE CONTRAST MICROSCOPY; PHOTOCHEMOTHERAPY; TIME; TUMOR CELL LINE; WESTERN BLOTTING;

AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SEPARATION; CHAPERONIN 60; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; FLOW CYTOMETRY; HSP70 HEAT-SHOCK PROTEINS; HUMANS; HYPERTHERMIA, INDUCED; LIGHT; MEMBRANE POTENTIALS; MICROSCOPY, PHASE-CONTRAST; MITOCHONDRIA; OSTEOSARCOMA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; TIME FACTORS;

EID: 24644490076     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.27.1.193     Document Type: Article

References (42)

1. Morgan J and Oseroff AR: Mitochondria-based photodynamic anti-cancer therapy. Adv Drug Deliv Rev 49: 71-86, 2001.
2. Raab O: Über die wirking fluoresciender stoffe auf infusoria. Ztschr Boil 39: 542-546, 1900.
3. Lipson RL and Baldes EJ: The photodynamic properties of a particular hematoporphyrin derivative. Arch Dermatol 82:508-516,1960.
4. Moan J, van den Akker J, Juzenas P, Ma LW, Angell-Petersen E, Gadmar 0B and Iani V: On the basis for tumor selectivity in the 5-aminolevulinic acid-induced synthesis of protoporphrin IX. J Porphyr Phthalocya 5: 170-176, 2001.
5. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE and Nesland JM: 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 79: 2282-2308, 1997.
6. Harmon BV, Corder AM, Collins RJ, Gobe GC, Allen J, Allan DJ and Kerr JF: Cell death induced in a murine mastocytoma by 42-47 degrees C heating in vitro: evidence that the form of death changes from apoptosis to necrosis above a critical heat load. Int J Radiât Biol 58: 845-858, 1990.
7. Remani P, Ostapenko VV, Akagi K, Bhattathiri VN, Nair MK and Tanaka Y: Relation of transmembrane potential to cell survival following hyperthermia in HeLa cells. Cancer Lett 144: 117-123, 1999.
8. Yuen WF, Fung KP, Lee CY, Choy YM, Kong SK, Ko S and Kwok TT: Hyperthermia and tumour necrosis factor-alpha induced apoptosis via mitochondrial damage. Life Sci 67: 725-732, 2000.
9. Orenstein A, Kostenich G, Kopolovic Y, Babushkina T and Malik Z: Enhancement of ALA-PDT damage by IR-induced hyperthermia on a colon carcinoma model. Photochem Photobiol 69:703-707, 1999.
10. Kelleher DK, Bastian J, Thews O and Vaupel P: Enhanced effects of aminolaevulinic acid-based photodynamic therapy through local hyperthermia in rat tumours. Br J Cancer 89: 405-411, 2003.
11. Yokoyama K and Oku T: Relief from the pain of the juvenile rheumatoid arthritis-affected temporomandibular joint by the irradiation of linear polarized near infrared ray. Pain Clinic 10: 197-202, 1998.
12. Yokoyama K and Sugiyama K: Temporomandibular joint pain analgesia linearly polarized near-infrared irradiation. Clin J Pain 17:47-51,2001.
13. Nomura J, Yanase S, Matsumura Y, Nagai K and Tagawa T: Efficacy of combined photodynamic and hyperthermic therapy with a new light source in an in vivo osteosarcoma tumor model. J Clin Laser Med Surg 22: 3-8, 2004.
14. Tagawa T, Nomura J, Kihira H and Murata M: A newly established osteosarcoma cell line from mandible. Mie Medical J 39: 279-286, 1989.
15. Tsai T, Hong RL, Tsai JC, Lou PJ, Ling IF and Chen CT: Effect of 5-aminolevulinic acid-mediated photodynamic therapy on MCF-7 and MCF-7/ADR cells. Lasers Surg Med 34: 62-72, 2004.
16. Scidl J, Rauch J, Krieg RC, Appel S, Baumgartner R and Knuechel R: Optimization of differential photodynamic effectiveness between normal and tumor urothelial cells using 5-aminolevulinic acid-induced protoporphyrin IX as sensitizer. Int J Cancer 92: 671-677, 2001.
17. Valeriote F and Lin H: Synergistic interaction of anticancer agents: a cellular perspective. Cancer Chemother Rep 59: 895-900, 1975.
18. Kamei T, Inui M, Nakamura S, Okumura K, Goto A and Tagawa T; Interferon-gamma and anti-Fas antibody-induced apoptosis in human melanoma cell lines and its relationship to bcl-2 cleavage and bak expression. Melanoma Res 13: 153-159, 2003.
19. Fink-Puches R, Wolf P and Kerl H: Photodynamic therapy of superficial basal cell carcinoma by instillation of aminolevulinic acid and irradiation with visible light. Arch Dermatol 133: 1494-1495, 1997.
20. Wilson BC, Olivo M and Singh G: Subcellular localization of Photofrin and aminolevulinic acid and photodynamic crossresistance in vitro in radiation-induced fibrosarcoma cells sensitive or resistant to photofrin-mediated photodynamic therapy. Photochem Photobiol 65: 166-176, 1997.
21. Douwes F, Bogovic J, Douwes O, Migeod F and Grote C: Whole-body hyperthermia in combination with platinumcontaining drugs in patients with recurrent ovarian cancer. Int J Clin Oncol 9: 85-91, 2004.
22. Van Vulpen M, De Leeuw AA, Raaymakers BW, van Moorselaar RJ, Hofman P, Lagendijk JJ and Battermann JJ: Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: preliminary results. BJU Int 93:36-41,2004.
23. Rasch MH, Tijssen K, van Steveninck J and Dubbelman TM: Synergistic interaction of photodynamic treatment with the sensitizer aluminum phthalocyanine and hyperthermia on loss of clonogenicity of CHO cells. Photochem Photobiol 64: 586-593, 1996.
24. Chen B, Xu Y, Agostinis P and De Witte PA: Synergistic effect of photodynamic therapy with hypericin in combination with hyperthermia on loss of clonogenicity of RIF-1 cells. Int J Oncol 18: 1279-1285,2001.
25. Tsujino I, Anderson GS and Sieber F: Postirradiation hyperthermia selectively potentiates the merocyanine 540-sensitized photoinactivation of small cell lung cancer cells. Photochem Photobiol 73: 191-198, 2001.
26. Christensen T, Smedshammer L, Wahl A and Moan J: Photodynamic effects and hyperthermia in vitro. Adv Exp Med Biol 193:69-78,1985.
27. Christensen T, Wahl A and Smedshammer L: Effects of haematoporphyrin derivative and light in combination with hyperthermia on cells in culture. Br J Cancer 50: 85-89, 1984.
28. Prinsze C, Dubbelman TM and van Steveninck J: Potentiation of thermal inactivation of glyceraldehyde-3-phosphate dehydrogenase by photodynamic treatment. A possible model for the synergistic interaction between photodynamic therapy and hyperthermia. Biochem J 276: 357-362, 1991.
29. Moor AC: Signaling pathways in cell death and survival after photodynamic therapy. J Photochem Photobiol B 57: 1-13, 2000.
30. Kessel D and Luo Y: Photodynamic therapy: a mitochondrial inducer of apoptosis. Cell Death Differ 6: 28-35, 1999.
31. V arnes ME, Chiu SM, Xue LY and Oleinick NL: Photodynamic therapy-induced apoptosis in lymphoma cells: translocation of cytochrome c causes inhibition of respiration as well as caspase activation. Biochem Biophys Res Commun 255: 673-679, 1999.
32. Pignatelli D, Ferreira J, Soarés P, Costa MJ and Magalhaes MC: Immunohistochemical study of heat shock proteins 27, 60 and 70 in the normal human adrenal and in adrenal tumors with suppressed ACTH production. Microsc Res Tech 61: 315-323, 2003.
33. Voos W and Rottgers K: Molecular chaperones as essential mediators of mitochondrial biogenesis. Biochim Biophys Acta 1592:51-62,2002.
34. Hanlon JG, Adams K, Rainbow AJ, Gupta RS and Singh G: Induction of Hsp60 by Photofrin-mediated photodynamic therapy. J Photochem Photobiol B 64: 55-61, 2001.
35. Rucker N, Ferrario A and Corner CJ: Constitutive overexpression of HSP-70 in thermal resistant tumor cells does not alter sensitivity to porphyrin-, chlorin-, or purpurin-mediated PDT. J Porphyrins Phthalocyanines 5: 143-146, 2001.
36. Shackley DC, Haylett A, Whitehurst C, Betts CD, OFlynn K, Clarke NW and Moore JV: Comparison of the cellular molecular stress responses after treatments used in bladder cancer. BJU Int 90: 924-932, 2002.
37. Cosserat-Gerardin I, Bezdetnaya L, Notter D, Vigneron C and Guillemin F: Biosynthesis and photodynamic efficacy of protoporphyrin IX (PpIX) generated by 5-aminolevulinic acid (ALA) or its hexylester (hALA) in rat bladder carcinoma cells. J Photochem Photobiol B 59: 72-79, 2000.
38. Harmon BV, Takano YS, Winterford CM and Gobe GC: The role of apoptosis in the response of cells and tumours to mild hyperthermia. Int J Radiat Biol 59: 489-501, 1991.
39. Samali A, Cai J, Zhivotovsky B, Jones DP and Orrenius S: Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and HsplO in the mitochondrial fraction of jurkat cells. EMBO J 18:2040-2048, 1999.
40. Xanthoudakis S, Roy S, Rasper D, et at. Hsp60 accelerates thematuration of pro-caspase-3 by upstream activator proteases during apoptosis. EMBO J 18: 2049-2056, 1999.
41. Kuzelova K, Grebenova D, Pluskalova M, Marinov I and Hrkal Z: Early apoptotic features of K562 cell death induced by 5-aminolaevulinic acid-based photodynamic therapy. J Photochem Photobiol B 73: 67-78, 2004.
42. Grebenova D, Kuzelova K, Smetana K, et al: Mitochondrial and endoplasmic reticulum stress-induced apoptotic pathways are activated by 5-aminolevulinic acid-based photodynamic therapy in HL60 leukemia cells. J Photochem Photobiol B 69: 71-85, 2003.